Merck Research Laboratories Expands into South San Francisco

Merck Research Laboratories (MRL) South San Francisco will be an active participant in the local biomedical community and an integral part of Merck's world-class network of medicines and vaccines.

* All images represent architectural concepts. Courtesy of Alexandria Real Estate Equities, Inc.

Merck Research Laboratories (MRL), the arm of our company focused on discovering and developing therapies to improve patients’ lives, is expanding its discovery capabilities in South San Francisco by breaking ground on a new, cutting-edge research facility, scheduled to be operational in 2019. Construction will begin in 2017 on the new South San Francisco site, which will build upon Merck’s established Bay Area presence while strengthening our discovery research capabilities.

The new nine-story, multi-disciplinary discovery research facility, centrally located on East Grand Avenue, will accommodate more than 300 scientists and support research spanning exploratory biology through early clinical development. The building is being custom designed with an open atmosphere that encourages collaboration and team work. The site will also have a large auditorium to provide space for nearby academics, scientists and entrepreneurs to convene and engage in scientific dialogue.

We're hiring in South San Francisco!

We’re starting research operations at Merck’s interim location in South San Francisco in early 2017 and are actively recruiting. Scientists will have access to leading-edge resources to explore the most promising science, with an initial focus on therapeutic applications in cardiovascular, metabolic and renal disease.